The plan would let compounding pharmacies temporarily make popular peptides like BPC-157, per two people familiar with it, even though FDA staff scientists flagged safety gaps.
Recap by typeshit. Full story at Boston Herald.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
The Telangana Drugs Control Administration issued a strict warning over unapproved weight-loss drugs and peptides being sold online in the Indian state.
An August 2025 ruling sided with Novo Nordisk and Lilly. Plaintiffs need an accepted test, not just symptoms or records, and testing after stopping the drug can complicate a claim.
Vox lays out why plans are dropping weight loss drugs after coverage hit about two in three employers, with surveys showing more cuts coming in 2027.
Loading…